A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
Lay Description
Category
- Healthy Subjects Needed
- Child Health
- Wounds and Injuries
- IRB Number
- 20200668HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Diana Anzueto Guerra
210-567-5225
anzuetod@uthscsa.edu
Principal Investigator
Michael Odom